文献库搜索 | GeneLibs

Sato(K),Shigekawa(M),Yoshioka(T),Daiku(K),... DEN Open 2027-04-00

...cancer patients, and reports of the effectiveness of neoadjuvant therapy are emerging. Accordingly, developing optimal d...

Shibata(S),Horiguchi(SI),Koizumi(K),Sadato... DEN Open 2027-04-00

...Cancer of the Colon and Rectum (JSCCR) criteria. In patients with T1b colon cancer, the WH-por approach demonstrated fav...

Xu(H),Wei(F),Hou(M),Zhong(L),Feng(Y),Shen(XC) Biomaterials 2027-01-00

...cancer cells and activate the immune response. However, its efficacy is limited by the tumor hypoxic microenvironment. M...

Nie(W),Luan(T),Liu(C),Sun(G),Lei(Q),Liu(X)... Biomaterials 2027-01-00

Triple-negative breast cancer (TNBC) remains a significant clinical challenge due to the lack of actionable targets, dos...

Guo(Z),Liang(X),Ding(H),Zhou(Z),Yang(C) Biomaterials 2027-01-00

The immunosuppressive tumor microenvironment (TME) in non-small cell lung cancer (NSCLC), particularly the dominance of ...

Deng(Z),Wu(X),Huang(T),Chen(H),Wu(Z),Liu(L... Biomaterials 2027-01-00

Intracellular polyamine metabolic homeostasis is closely linked to therapeutic outcomes in cancer. However, their intrin...

Shionoya(K),Tonozuka(R),Mukai(S),Joyama(Y)... DEN Open 2027-04-00

...cancer was 95.8%. The AE rate was 1.1% (14/1232), including pancreatitis (six), hemorrhage (five), hematoma (two), and p...

McGarrigle(V),Shimamura(Y),Zorron Cheng Ta... DEN Open 2027-04-00

...cancers. Although EFTR offers a minimally invasive alternative to surgery, data on efficacy, safety, and predictors of a...

Kikuchi(Y),Hagiwara(N),Kawami(N),Sakurazaw... DEN Open 2027-04-00

...cancer.

Zhang(Y),Ma(M),Lin(L),Liang(R),Gan(W),Wang... Biomaterials 2027-01-00

...cancer immunotherapy, but colorectal cancer (CRC) remains difficult to treat due to a complex immunosuppressive tumor mi...